Edwards Lifesciences Corporation Long-Lived Assets
Edwards Lifesciences Corporation (EW) had Long-Lived Assets of $1.91 billion as of 2025-12-31, per its 10-K filed 2026-02-25.
Financial Statements › Notes › Segment Reporting
us-gaap:NoncurrentAssets · last filed 2026-02-25
- 2025-12-31: Long-Lived Assets $1.91B.
- 2024-12-31: Long-Lived Assets $1.78B.
- 2023-12-31: Long-Lived Assets $1.68B; Long-Lived Assets as first filed $1.84B.
- 2022-12-31: Long-Lived Assets $1.57B; Long-Lived Assets as first filed $1.73B.
| Period end | Long-Lived Assets | Long-Lived Assets as first filed |
|---|---|---|
| 2025-12-31 | $1.91B 10-K · filed 2026-02-25 | |
| 2024-12-31 | $1.78B 10-K · filed 2026-02-25 | |
| 2023-12-31 | $1.68B 10-K · filed 2026-02-25 | $1.84B 10-K · filed 2024-02-12 |
| 2022-12-31 | $1.57B 10-K · filed 2025-02-28 | $1.73B 10-K · filed 2023-02-13 |
| 2021-12-31 | $1.75B 10-K · filed 2024-02-12 | |
| 2021-09-30 | $1.68B 10-Q · filed 2021-10-29 | |
| 2021-06-30 | $1.63B 10-Q · filed 2021-07-30 | |
| 2021-03-31 | $1.63B 10-Q · filed 2021-04-28 | |
| 2020-12-31 | $1.61B 10-K · filed 2023-02-13 | |
| 2020-09-30 | $1.50B 10-Q · filed 2020-10-26 | |
| 2020-06-30 | $1.43B 10-Q · filed 2020-07-27 | |
| 2020-03-31 | $1.32B 10-Q · filed 2020-04-28 | |
| 2019-12-31 | $1.24B 10-K · filed 2022-02-14 | |
| 2019-09-30 | $1.15B 10-Q · filed 2019-10-25 | |
| 2019-06-30 | $1.08B 10-Q · filed 2019-07-26 | |
| 2019-03-31 | $1.04B 10-Q · filed 2019-04-26 | |
| 2018-12-31 | $899.80M 10-K · filed 2021-02-12 | |
| 2018-09-30 | $856.60M 10-Q · filed 2018-10-26 | |
| 2018-06-30 | $800.70M 10-Q · filed 2018-07-27 | |
| 2018-03-31 | $765.00M 10-Q · filed 2018-04-27 | |
| 2017-12-31 | $784.40M 10-K · filed 2020-02-14 | |
| 2017-09-30 | $755.70M 10-Q · filed 2017-10-27 | |
| 2017-06-30 | $741.00M 10-Q · filed 2017-07-28 | |
| 2017-03-31 | $713.00M 10-Q · filed 2017-04-28 | |
| 2016-12-31 | $700.00M 10-K · filed 2019-02-15 | |
| 2016-09-30 | $668.50M 10-Q · filed 2016-10-28 | |
| 2016-06-30 | $642.60M 10-Q · filed 2016-07-29 | |
| 2016-03-31 | $628.40M 10-Q · filed 2016-04-29 | |
| 2015-12-31 | $613.70M 10-K · filed 2018-02-16 | |
| 2015-09-30 | $509.70M 10-Q · filed 2015-10-29 | |
| 2015-06-30 | $508.30M 10-Q · filed 2015-07-29 | |
| 2015-03-31 | $498.50M 10-Q · filed 2015-04-29 | |
| 2014-12-31 | $492.10M 10-K · filed 2017-02-17 | |
| 2014-09-30 | $467.20M 10-Q · filed 2014-10-31 | |
| 2014-06-30 | $458.20M 10-Q · filed 2014-08-04 | |
| 2014-03-31 | $453.90M 10-Q · filed 2014-05-02 | |
| 2013-12-31 | $457.00M 10-K · filed 2016-02-19 | |
| 2013-09-30 | $440.00M 10-Q · filed 2013-11-07 | |
| 2013-06-30 | $424.60M 10-Q · filed 2013-08-06 | |
| 2013-03-31 | $457.00M 10-Q · filed 2014-05-02 | $411.00M 10-Q · filed 2013-05-06 |
| 2012-12-31 | $399.60M 10-K · filed 2015-02-20 | |
| 2012-09-30 | $354.70M 10-Q · filed 2012-11-07 | |
| 2012-06-30 | $341.60M 10-Q · filed 2012-08-07 | |
| 2012-03-31 | $334.00M 10-Q · filed 2012-05-09 | |
| 2011-12-31 | $328.90M 10-K · filed 2014-02-28 | $353.50M 10-K · filed 2012-02-27 |
| 2011-09-30 | $311.00M 10-Q · filed 2011-11-08 | |
| 2011-06-30 | $292.90M 10-Q · filed 2011-08-08 | |
| 2011-03-31 | $328.90M 10-Q · filed 2012-05-09 | |
| 2010-12-31 | $282.80M 10-K · filed 2013-02-28 | |
| 2009-12-31 | $265.00M 10-K · filed 2012-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| STERIS plc (STE) | Ireland | $20.343B | 25.49 |
| ZIMMER BIOMET HOLDINGS, INC. (ZBH) | United States | $17.103B | 20.66 |
| ALIGN TECHNOLOGY INC (ALGN) | United States | $10.346B | 29.06 |
| MSA Safety Inc (MSA) | United States | $7.023B | 21.47 |
| ESTABLISHMENT LABS HOLDINGS INC. (ESTA) | $1.954B | -65.76 | |
| Cadre Holdings, Inc. (CDRE) | United States | $1.123B | 33.88 |
| Enovis CORP (ENOV) | United States | $1.053B | -1.18 |
| Anteris Technologies Global Corp. (AVR) | United States | $0.746B | |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |
| Inogen Inc (INGN) | United States | $0.139B | -7.00 |